BOBeryne Odeny

Beryne Odeny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beryne Odeny has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From mammogram to lung scan: Lessons learned toward an implementation roadmap for integrating breast and lung cancer screening

    by Beryne Odeny, Ria Dave, Aren Baghdasar M, Jordan Foy, Alex T. Ramsey, Thomas Odeny, Sanjeev Bhalla, Mackenzie Hofford, Kim Lori Sandler, Aimee James, et al.

  • Open Access

    Time-to-Statin Prescription for Primary Atherosclerotic Cardiovascular Disease Prevention in a Lung Cancer Screening Program in Missouri: A Retrospective Cohort Study

    by Isaac Che Ngang, Eyerusalem Zewde, Sridharan Gopalsamy Ramaswamy, Akila Anandarajah, Benjamin Bowe, Beryne Odeny

    Background: Individuals undergoing lung cancer screening (LCS) represent a population at high risk for atherosclerotic cardiovascular disease (ASCVD), yet opportunities for cardiovascular prevention during screening encounters may be underutilized. While prior studies have examined whether statins are prescribed in eligible patients, little is known about the timing of statin initiation following LCS, particularly among statin-naïve individuals. Methods: We conducted a retrospective cohort study using electronic health record data from a large academic health system in Missouri. Adults aged 50–80 who underwent LCS between January 1, 2015, and December 31, 2023, were statin-naïve, and met 2019 ACC/AHA criteria for primary prevention were included. The primary outcome was time-to-statin initiation following LCS. Kaplan–Meier methods and Cox proportional hazards models were used to evaluate timing and predictors of statin initiation across demographic, clinical, and socioeconomic subgroups. Results: Among 3,100 statin-eligible, statin-naïve individuals who had undergone LCS, only 27.3% were prescribed a statin within one year of LCS. Uptake accrued gradually (10.5% by 90 days; 17.8% by 180 days; 23.2% by 270 days; 27.1% by 360 days). In adjusted models, earlier statin initiation was independently associated with a higher ASCVD risk category, a cardiology visit in the year preceding LCS, and former (versus current) smoking; older age and male sex were associated with slower initiation. Race, insurance type, and area deprivation were not independently associated with time-to-statin initiation. Conclusions: Despite high ASCVD risk, most statin-eligible patients undergoing LCS did not receive timely statin therapy. Earlier initiation tracked calculated ASCVD risk and specialty (cardiology) contact rather than race, sex, insurance, or area deprivation. Because most patients at high calculated risk still went untreated, integrating cardiovascular risk assessment and preventive decision support into LCS workflows may help reduce missed opportunities for ASCVD prevention.

  • Open Access

    End-user perspectives on design and implementation of a novel SkinScan3D (SS3D) device for monitoring Kaposi Sarcoma in East Africa: a qualitative study

    by Philippa Kadama Makanga, Harriet F. Adhiambo, Dorothy Mangale, Martha Nansereko, Jane Frances Nalubega, Roselyn Knight, Elvin Geng, Victor Mudhune, Elizabeth Bukusi, Fred Okuku, et al.

    Introduction: SkinScan3D (SS3D) is a novel, artificial intelligence–enabled device that provides objective three-dimensional measurements for monitoring Kaposi Sarcoma (KS) lesions. Prior to launching a clinical trial of the device, we obtained end-user perspectives to guide device refinement. Methods: Between April and May 2025, we conducted six focus group discussions and 28 in-depth interviews with patients, healthcare providers, and community representatives in Kenya and Uganda. Participants viewed a demonstration video and handled the SS3D prototype. Data were analyzed using hybrid deductive-inductive thematic analysis informed by the Health Information Technology Usability Evaluation Model and the Consolidated Framework for Implementation Research. Results: Qualitative findings were synthesized into a conceptual framework for SS3D adoption with two interconnected themes: 1) experiences and context, and 2) device perceptions and implementation factors. Participants’ receptivity to the device was first shaped by experiences with medical technologies and the broader sociocultural context, including trust in providers, health beliefs, and gender preferences. After interacting with the prototype, participants viewed the SS3D as intuitive, accurate, and potentially capable of improving the objectivity and efficiency of KS lesion monitoring. They identified concerns related to safety, infection prevention, data security, affordability, maintenance, and workflow integration. Successful implementation was perceived to depend on device refinement, supportive organizational factors, including leadership engagement, provider training, maintenance capacity, and patient education to address misconceptions about the device. Participants proposed hardware, software, connectivity, and training refinements to support safe integration into routine clinical care. Conclusion: End users demonstrated overall satisfaction and receptivity to the SS3D, given potential benefits for both patients and providers. We identified targeted refinements to optimize the device’s functionality and integration into the oncology environment to improve its fit with the local context.

  • Open Access

    An emerging TIMER-2C framework for addressing barriers to research culture and productivity among local healthcare providers in the Middle East and sub-Saharan Africa: A qualitative study and modified Delphi approach

    by Beryne Odeny, Dorothy Mangale, Dhananjaya Sharma, Mariam Balogun, Elizabeth Bukusi, Fatima Suleman, Miliard Derbew, Juliet Iwelunmor, Ermyas Birru, Isaac Che Ngang, et al.

    Contributions from healthcare professionals in the Middle East and North Africa (MENA) and sub-Saharan Africa (SSA) to global health research remain disproportionately low. We conceptualized the TIMER-2C framework to capture the multi-level barriers and facilitators shaping research productivity among local healthcare professionals in MENA and SSA. We conducted qualitative interviews using a modified Delphi approach comprising two rounds to: 1) identify barriers and facilitators, and 2) establish consensus on the most prominent factors influencing research productivity. We purposively sampled 17 participants from Jordan, Qatar, Egypt, Lebanon, North Sudan, South Sudan, Nigeria, Ghana, Kenya, Uganda, Ethiopia, South Africa and India. Interview guides were grounded in theoretical frameworks. Transcripts were analyzed for barriers, facilitators, and recommendations for increasing research output. Barriers and facilitators to research productivity occurred at individual, institutional, national, and global levels. Key barriers included limited time, funding, mentorship, and research training; institutional prioritization of clinical and teaching duties over research; lack of national investment and supportive policies; and global challenges in funding, publishing, and collaboration. Facilitators included personal motivation, protected time, access to training and mentorship, institutional support for research, national funding strategies, and meaningful global partnerships that value local contributions. We identified six themes and one overarching theme from which we coined the TIMER-2C framework: 1) T ime, 2) I nstability, Interest & Infrastructure, 3) M oney & Resources, 4) E xpertise & Experience, 5) R ecognition, and 6) constructive C ollaboration, together fostering a positive research C ulture (2C). Research culture emerged as an overarching influence on research contributions. We unveil an emerging framework, the TIMER-2C , that depicts relationships among multilevel factors shaping research productivity and offers a useful tool to guide and evaluate local capacity-building strategies. We recommend further application of this framework to guide the design, implementation and evaluation of multi-pronged strategies to enhance research contributions from MENA, SSA, and similar contexts.


  • Open Access

    Differences in lung cancer screening outcomes and follow-up by patient, provider and place-based characteristics in Missouri and Illinois: A cross-sectional study

    by Akila Anandarajah, Vaishnavi Mamillapalle, Benjamin Bowe, Isaac Che Ngang, Alex Ramsey, Beryne Odeny

    Background Lung cancer remains the leading cause of cancer-related mortality in the United States, yet disparities in lung cancer screening (LCS) outcomes exist and remain understudied, particularly in the Midwestern region. Our objective was to investigate disparities in lung radiology outcomes and follow-up care based on patient, provider, and place-based characteristics (i.e., area deprivation index; ADI). Methods This cross-sectional study used data from the LCS program at Siteman Cancer Center (SCC) in St. Louis, Missouri, from January to December 2023. SCC’s catchment area includes 82 counties in Missouri and Illinois; approximately 15% of the population reside in a rural zip code, and 29% reside in medically underserved areas 80% are White. The study included 1,946 individuals aged 50–80, meeting LCS eligibility criteria based on smoking history and age. Lung radiology findings were assessed as primary outcomes, and timely follow-up adherence (i.e., return for follow-up visit) was analyzed among patients with high-risk findings (Lung-RADS 3 [”Probably Benign”] and 4 [”Suspicious”]) from January to June 2023, requiring follow-up by December 2023. Multivariable logistic regression was conducted, adjusting for patient and provider characteristics and ADI. Results Of the 1,946 individuals who accessed LCS, 57% were Black, 41% White, 1% Asian, and 1% of another race; 54% were male and 46% female. Lung findings were classified as "probably benign/suspicious" (high risk) for 14%. Annual visits were associated with higher likelihood of high-risk scores compared to baseline visits (AOR = 2.10 (1.40–3.15); p < 0.001). Racial differences were noted in the association between provider type and lung outcomes. Among White individuals only, specialist compared to primary care provider referral was associated with increased odds of being high risk (AOR = 1.58 (1.00–2.50); p = 0.048). Sex, insurance, smoking status, park-years and ADI were not associated with lung radiology outcomes. Timely adherence to return follow-up visit among high-risk patients was suboptimal, with only 20.0% returning within 3–6 months for their repeat LCS. Individuals residing in moderate ADI (distress) areas were less likely to have timely follow-up (for high-risk findings) compared to those in high distress (AOR = 0.393, 95% CI = 0.155–1.001, p = 0.050). There were no differences by sex, insurance, smoking status, and pack-years for being classified as high risk. Conclusions SCC’s LCS program successfully captured Black populations and individuals from highly distressed areas, in a predominantly White catchment area. There were no observable race disparities in timely follow-up of high-risk findings, reflecting progress toward equity in access and outcomes. Place-based disparities in follow-up were observed that warrant further characterization and risk assessment to improve follow-up of patients undergoing LCS.


  • Open Access

    Comparative analysis of HIV data completeness in Haiti’s iSanté Plus Electronic Medical Record system across children, adolescents and adults: a cross-sectional evaluation of 2016–2022 data

    by Beryne Odeny, Jean Guy Honoré, Jean Gabriel Balan, James P Hughes, Bradley Wagenaar, Stephen Gloyd, Kemar Célestin, Marinho Elisma, Kesner Francois, Nancy Puttkammer

    Objective To evaluate and compare documentation completeness of HIV-related data by age group (children, adolescents and adults) in Haiti’s Electronic Medical Record (EMR) system. Design Cross-sectional evaluation. Setting EMR data for 36 965 enrolment visits, and 123 608 return visits from 58 facilities in Haiti (from 2016 to 2022). Participants Children, adolescents and adults accessing HIV care and treatment services in Haiti. Main exposure measure Health facility attendance for HIV-related healthcare. Main outcome measure Level of data completeness, as a measure of data quality. We developed Composite Completeness Scores (CCS scores) to measure data completeness. Lower scores meant lower completeness. Generalised linear models were used to investigate factors associated with completeness. Results At the enrolment visit, most patients were adults (81.6%) and female (56.7%). Most facilities were health centres (75.9%). The overall average enrolment visit CCS score was 54.0%. At enrolment, being a child (CCS score difference=−7.08, 95% CI: −11.31 to −2.86) and a more recent year of enrolment (−6.01, 95% CI: −11.69 to −0.33) were significantly associated with lower completeness scores than being an adult and having an earlier year of enrolment, respectively. The overall average return visit CCS score was 49.6%. At the return visit, children (−6.76, 95% CI: −10.07 to −3.45) had significantly lower average completeness scores than adults. For first viral load documentation, children had lower odds of completeness compared with adults (adjusted OR=0.21, 95% CI: 0.16 to 0.28). Sex, year of enrolment, facility ownership (public, private, mixed), total patient volume and duration of EMR use were not significantly associated with completeness of documentation at the enrolment and return visits. Conclusions We observed disparities in electronic data completeness by age group, which may be indicative of digital health disparities. Documentation was particularly poor among children and declined over time for enrolment visits. Further research is needed to understand and address these documentation gaps.


  • Open Access

    An emerging TIMER-2C framework for addressing barriers to research culture and productivity among local healthcare providers in the Middle East and sub-Saharan Africa: a qualitative study and modified Delphi approach

    by Beryne Odeny, Dorothy Mangale, Dhananjaya Sharma, Mariam Balogun, Elizabeth Bukusi, Fatima Suleman, Miliard Derbew, Juliet Iwelunmor, Ermyas Birru, Isaac Che Ngang, et al.

    Background: Contributions from healthcare professionals in the Middle East and North Africa (MENA) and sub-Saharan Africa (SSA) to global health research remain disproportionately low. we conceptualized the TIMER-2C framework as emerging approach to capture the multilevel barriers and facilitators shaping research productivity among local healthcare professionals in MENA and SSA. Methods: We conducted qualitative interviews with a modified Delphi approach comprising two rounds of interviewing to: 1) identify barriers and facilitators, and 2) establish consensus on the most prominent factors influencing research productivity. We purposively sampled 17 established and early career health researchers from Jordan, Qatar, Egypt, Lebanon, North Sudan, South Sudan, Nigeria, Ghana, Kenya, Uganda, Ethiopia, South Africa and India. Interview guides were grounded in the “Capacity Strengthening of Health Research in Conflict” and the “Health Equity Implementation” frameworks. We explored barriers, facilitators, and recommendations for increasing research output. Transcripts were managed in ATLAS.ti and thematically analyzed to identify emerging themes. Results: Barriers and facilitators to research productivity occurred at individual, institutional, national, and global levels. Key barriers included limited time, funding, mentorship, and research training; institutional emphasis on clinical and teaching duties over research; lack of national investment and supportive policies; and global inequities in funding, publishing, and collaboration. Facilitators included personal motivation, protected time, access to training and mentorship, institutional support for research, national funding strategies, and equitable global partnerships that value research contributions from local healthcare professionals. We identified six interlinked core themes and one overarching theme from which we coined the TIMER-2C conceptual framework to represent: 1) T ime, 2) I nstability, Interest & Infrastructure, 3) M oney & Resources, 4) E xpertise & Experience, 5) R ecognition, and 6) constructive C ollaboration, which are elements that promote a positive research C ulture (2C stands for Collaboration and Culture) that builds research capacity and creates a sustainable pipeline of researchers. Conclusion: We identified research culture as an overarching influence on research contributions from MENA and SSA. We unveil an emerging conceptual framework, the TIMER-2C framework , that depicts and explains the relationship between factors associated with research productivity. This framework with its seven constructs can be a useful tool for guiding and/or evaluating local and global strategies to increase research output. We recommend further use of this framework to guide the design, implementation and evaluation of multi-pronged strategies to enhance research contributions from healthcare professionals in MENA, SSA, and other similar contexts.

  • Open Access

    Cardiovascular disease risk and Lung cancer screening for Early Assessment of Risk (project CLEAR) in Missouri: A protocol for a mixed methods study

    by Beryne Odeny, Isaac Che Ngang, Vaishnavi Mamillapalle, Mariam Balogun, Benjamin Bowe, Meera Muthukrishnan, Akila Anandarajah, Feng Gao, Aimee James, Graham Colditz

    Background Lung cancer and atherosclerotic cardiovascular disease (ASCVD) are leading causes of mortality in the United States, sharing common risk factors like smoking and age. Preventive care for these conditions is often siloed, leading to missed opportunities to prevent ASCVD-related mortality in lung cancer screening (LCS) patients. In various trial settings, patients undergoing LCS were more likely to die from ASCVD than from cancer; however, less than half of eligible patients got statin prescription. This study aims to understand the degree to which ASCVD risk assessment and prevention is done in routine “real-world” clinical settings providing LCS in Missouri. Our objectives are to determine the prevalence of statin eligibility, statin prescription and explore factors, disparities and barriers to statin therapy in people undergoing LCS. Methods A parallel convergent mixed-methods design will be used. Quantitative data from people undergoing LCS at Barnes-Jewish Healthcare System will be extracted from Epic electronic medical records (EMR) from January 2022-December 2023, capturing demographics, socioeconomic factors, and clinical data including ASCVD risk factors and statin use. We anticipate gathering about records for approximately 8,000 patients. Qualitative data will be gathered from in-depth interviews with up to 15 healthcare providers to identify barriers, facilitators and recommendations for enhancing statin therapy in people undergoing LCS. Discussion The risk of mortality is drastically heightened in people undergoing LCS who are not receiving statin therapy, and thus there is an urgent need to identify those who are eligible but not receiving ASCVD prevention. Promoting ASCVD risk assessment and prevention in LCS programs has the potential to mitigate the dual burden of ASCVD and lung cancer in high-risk populations who smoke cigarettes. This study will demonstrate the extent of the gap in statin therapy among LCS and provide insights into disparities, barriers and recommendations for integrating ASCVD risk assessment and prevention with LCS. Conclusion This study will provide real-world baseline data on statin therapy among people undergoing LCS in Missouri, and will highlight disparities, barriers and recommendations for integrating ASCVD prevention in LCS.

  • Open Access

    Shaping a new era of global health for greater impact: CUGH 2024 highlights

    by Beryne Odeny, Mariam Balogun, Nwaliweaku Anidi, Raghad Salma, Judith Mwobobia, Julia Robinson

    The Consortium of Universities for Global Health hosted its 15th annual conference in Los Angeles, California from 7 to 10 March 2024. Over 1400 global delegates gathered around the theme, ‘Global Health without Borders: Acting for Impact’ ( https://www.cugh2024.org).


  • Open Access

    Development of novel composite data quality scores to evaluate facility-level data quality in electronic data in Kenya: a nationwide retrospective cohort study

    by Beryne M. Odeny, Anne Njoroge, Steve Gloyd, James P. Hughes, Bradley H. Wagenaar, Jacob Odhiambo, Lilly M. Nyagah, Ayub Manya, Ooga Wesley Oghera, Nancy Puttkammer

    Background: In this evaluation, we aim to strengthen Routine Health Information Systems (RHIS) through the digitization of data quality assessment (DQA) processes. We leverage electronic data from the Kenya Health Information System (KHIS) which is based on the District Health Information System version 2 (DHIS2) to perform DQAs at scale. We provide a systematic guide to developing composite data quality scores and use these scores to assess data quality in Kenya. Methods: We evaluated 187 HIV care facilities with electronic medical records across Kenya. Using quarterly, longitudinal KHIS data from January 2011 to June 2018 (total N = 30 quarters), we extracted indicators encompassing general HIV services including services to prevent mother-to-child transmission (PMTCT). We assessed the accuracy (the extent to which data were correct and free of error) of these data using three data-driven composite scores: 1) completeness score; 2) consistency score; and 3) discrepancy score. Completeness refers to the presence of the appropriate amount of data. Consistency refers to uniformity of data across multiple indicators. Discrepancy (measured on a Z-scale) refers to the degree of alignment (or lack thereof) of data with rules that defined the possible valid values for the data. Results: A total of 5,610 unique facility-quarters were extracted from KHIS. The mean completeness score was 61.1% [standard deviation (SD) = 27%]. The mean consistency score was 80% (SD = 16.4%). The mean discrepancy score was 0.07 (SD = 0.22). A strong and positive correlation was identified between the consistency score and discrepancy score (correlation coefficient = 0.77), whereas the correlation of either score with the completeness score was low with a correlation coefficient of -0.12 (with consistency score) and -0.36 (with discrepancy score). General HIV indicators were more complete, but less consistent, and less plausible than PMTCT indicators. Conclusion: We observed a lack of correlation between the completeness score and the other two scores. As such, for a holistic DQA, completeness assessment should be paired with the measurement of either consistency or discrepancy to reflect distinct dimensions of data quality. Given the complexity of the discrepancy score, we recommend the simpler consistency score, since they were highly correlated. Routine use of composite scores on KHIS data could enhance efficiencies in DQA at scale as digitization of health information expands and could be applied to other health sectors beyondHIV clinics.